<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genes (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Genes (Basel)</journal-id><journal-id journal-id-type="publisher-id">genes</journal-id><journal-title-group><journal-title>Genes</journal-title></journal-title-group><issn pub-type="epub">2073-4425</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7924190</article-id><article-id pub-id-type="pmid">33672614</article-id><article-id pub-id-type="doi">10.3390/genes12020299</article-id><article-id pub-id-type="publisher-id">genes-12-00299</article-id><article-categories><subj-group subj-group-type="heading"><subject>Communication</subject></subj-group></article-categories><title-group><article-title>Analysis of the Differential Gene and Protein Expression Profiles of Corneal Epithelial Cells Stimulated with Alternating Current Electric Fields</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2336-5729</contrib-id><name><surname>Kowtharapu</surname><given-names>Bhavani S.</given-names></name><xref ref-type="aff" rid="af1-genes-12-00299">1</xref><xref ref-type="aff" rid="af2-genes-12-00299">2</xref><xref rid="c1-genes-12-00299" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Damaraju</surname><given-names>Jyoti</given-names></name><xref ref-type="aff" rid="af1-genes-12-00299">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4536-2318</contrib-id><name><surname>Singh</surname><given-names>Nitesh Kumar</given-names></name><xref ref-type="aff" rid="af3-genes-12-00299">3</xref></contrib><contrib contrib-type="author"><name><surname>Ziebart</surname><given-names>Josefin</given-names></name><xref ref-type="aff" rid="af4-genes-12-00299">4</xref></contrib><contrib contrib-type="author"><name><surname>Bader</surname><given-names>Rainer</given-names></name><xref ref-type="aff" rid="af4-genes-12-00299">4</xref></contrib><contrib contrib-type="author"><name><surname>Koczan</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="af5-genes-12-00299">5</xref></contrib><contrib contrib-type="author"><name><surname>Stachs</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="af2-genes-12-00299">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Korinek</surname><given-names>Vladimir</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-genes-12-00299"><label>1</label>L V Prasad Eye Institute, Kallam Anji Reddy Campus, Banjara Hills, Hyderabad 500034, India; <email>jyotidamaraju@outlook.com</email></aff><aff id="af2-genes-12-00299"><label>2</label>Department of Ophthalmology, Rostock University Medical Center, 18057 Rostock, Germany; <email>oliver.stachs@uni-rostock.de</email></aff><aff id="af3-genes-12-00299"><label>3</label>Centre for Cellular and Molecular Biology, Hyderabad 500039, India; <email>nitesh@ccmb.res.in</email></aff><aff id="af4-genes-12-00299"><label>4</label>Biomechanics and Implant Technology Research Laboratory, Department of Orthopedics, Rostock University Medical Center, 18057 Rostock, Germany; <email>josefin.ziebart@med.uni-rostock.de</email> (J.Z.); <email>rainer.bader@med.uni-rostock.de</email> (R.B.)</aff><aff id="af5-genes-12-00299"><label>5</label>Institute for Immunology, Rostock University Medical Center, 18057 Rostock, Germany; <email>dirk.koczan@med.uni-rostock.de</email></aff><author-notes><corresp id="c1-genes-12-00299"><label>*</label>Correspondence: <email>bhavani.k@lvpei.org</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>299</elocation-id><history><date date-type="received"><day>27</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>In cells, intrinsic endogenous direct current (DC) electric fields (EFs) serve as morphogenetic cues and are necessary for several important cellular responses including activation of multiple signaling pathways, cell migration, tissue regeneration and wound healing. Endogenous DC EFs, generated spontaneously following injury in physiological conditions, directly correlate with wound healing rate, and different cell types respond to these EFs via directional orientation and migration. Application of external DC EFs results in electrode polarity and is known to activate intracellular signaling events in specific direction. In contrast, alternating current (AC) EFs are known to induce continuous bidirectional flow of charged particles without electrode polarity and also minimize electrode corrosion. In this context, the present study is designed to study effects of AC EFs on corneal epithelial cell gene and protein expression profiles in vitro. We performed gene and antibody arrays, analyzed the data to study specific influence of AC EFs, and report that AC EFs has no deleterious effect on epithelial cell function. Gene Ontology results, following gene and protein array data analysis, showed that AC EFs influence similar biological processes that are predominantly responsive to organic substance, chemical, or external stimuli. Both arrays activate cytokine&#x02013;cytokine receptor interaction, MAPK and IL-17 signaling pathways. Further, in comparison to the gene array data, the protein array data show enrichment of diverse activated signaling pathways through several interconnecting networks.</p></abstract><kwd-group><kwd>corneal epithelial cells</kwd><kwd>electric fields</kwd><kwd>alternating current</kwd><kwd>microarray</kwd><kwd>antibody array</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-genes-12-00299"><title>1. Introduction</title><p>Endogenous electric fields (EFs) and wound currents are generated spontaneously in many tissues following injury and are present at the wound site during the process of wound healing [<xref rid="B1-genes-12-00299" ref-type="bibr">1</xref>]. Dynamic changes in wound-generated electric currents demonstrate that electrical signaling is an active response to injury [<xref rid="B2-genes-12-00299" ref-type="bibr">2</xref>]. Many types of cells respond to weak direct current (DC) EFs with a galvanotropic response (polarized shifting of cellular orientation in an EF), which is followed by a galvanotaxic response (migration of a cell in an EF) [<xref rid="B3-genes-12-00299" ref-type="bibr">3</xref>]. Different cell types from the same tissue can respond differently to the same electrical signal. Peculiar differences in Ca<sup>2+</sup>, Na<sup>+</sup>, and K<sup>+</sup> channels, surface charges, and specific membrane resistance may contribute to the inherent directional movement of cells during applied EFs [<xref rid="B4-genes-12-00299" ref-type="bibr">4</xref>]. In the cornea, injury-induced corneal wound currents directly correlate with the wound healing rate. In physiological conditions, the human cornea shows small outward currents (0.07 &#x003bc;A/cm&#x000b2;), which simultaneously increase up to 5-fold upon wounding (0.41 &#x003bc;A/cm&#x000b2;) for approximately 6 h [<xref rid="B5-genes-12-00299" ref-type="bibr">5</xref>]. The human corneal epithelium contains an active Na<sup>+</sup>/K<sup>+</sup>-ATPase transport system, with an inward flow of sodium ions and active outward transport of Cl<sup>&#x02212;</sup> ions across the stroma and epithelium, establishing a trans-epithelial potential difference. Wounding disrupts this potential difference and consequently leads to the flow of Na<sup>+</sup> and K<sup>+</sup> into the wound from the surrounding tissue, generating a laterally orientated physiological EF that can direct orientation and migration of corneal epithelial cells and enhance the epithelial wound healing rate by controlling the division axis in epithelial cells [<xref rid="B6-genes-12-00299" ref-type="bibr">6</xref>,<xref rid="B7-genes-12-00299" ref-type="bibr">7</xref>].</p><p>The behavior of corneal epithelial cells and keratocytes varies in applied DC EFs, where epithelial cells, at field strength of 400 V/m, migrate in the cathodal direction and stromal fibroblasts (600 V/m) migrate in the anodal direction [<xref rid="B8-genes-12-00299" ref-type="bibr">8</xref>]. Applied external EF stimulations also influence the axis of corneal epithelial cell division, and in the presence of small EFs (e.g., 100 V/m), cultured corneal epithelial cell migration, orientation display serum, growth factor and substrate dependence in vitro [<xref rid="B9-genes-12-00299" ref-type="bibr">9</xref>,<xref rid="B10-genes-12-00299" ref-type="bibr">10</xref>]. Application of high EFs, for example 250 V/m, is necessary to observe cathodal migration of corneal epithelial cells in serum-free culture conditions. Further, human and bovine corneal epithelial cells show similar migration patterns in the applied small EFs [<xref rid="B11-genes-12-00299" ref-type="bibr">11</xref>,<xref rid="B12-genes-12-00299" ref-type="bibr">12</xref>]. The strength of the EFs in the vicinity of the lesion also influences the rate of re-epithelialization [<xref rid="B13-genes-12-00299" ref-type="bibr">13</xref>], while increased wound field strengths enhance corneal wound epithelialization. Studies on the role of wound-induced electrical currents show that Cl<sup>&#x02212;</sup> and Na<sup>+</sup> are the major components of electric currents in rat corneal wounds. In the resting, non-wounded cornea, Na<sup>+</sup> is the main component of ionic transport, whereas Cl<sup>&#x02212;</sup> is an important component of the endogenous EF at the wound edges. These findings allowed researchers to test clinically approved pharmacological agents such as aminophylline, ascorbic acid, and furosemide to control the Cl<sup>&#x02212;</sup> flow, thereby modulating electric currents in wounds [<xref rid="B14-genes-12-00299" ref-type="bibr">14</xref>]. The same approach in the form of chloride-free or aminophylline eye drops has been shown to enhance healing of damaged human corneas by offering bioelectric stimulation without electrodes [<xref rid="B5-genes-12-00299" ref-type="bibr">5</xref>]. At the cellular level, corneal injury causes significant changes in distribution and expression pattern of the calcium-activated chloride channel CLC2 in the human corneal epithelium. The time course of CLC2 mRNA upregulation correlates with increased Cl<sup>&#x02212;</sup> flux, which sequentially reaches its maximum within 1 h after wounding [<xref rid="B2-genes-12-00299" ref-type="bibr">2</xref>]. Furthermore, applied EFs also influence the regeneration of nerves after injury [<xref rid="B15-genes-12-00299" ref-type="bibr">15</xref>] and wound-generated endogenous EFs also control the rate of nerve sprouting, nerve growth, and regeneration, along with epithelial wound healing [<xref rid="B16-genes-12-00299" ref-type="bibr">16</xref>,<xref rid="B17-genes-12-00299" ref-type="bibr">17</xref>].</p><p>All of the literature reports so far regarding the application of external EFs in corneal wound healing have reported on the application of DC EFs. However, in certain cell types, the application of DC EFs has been shown to negatively affect cell viability and proliferation when compared to alternating current (AC) EFs [<xref rid="B18-genes-12-00299" ref-type="bibr">18</xref>,<xref rid="B19-genes-12-00299" ref-type="bibr">19</xref>], suggesting cell survival benefits of AC EFs [<xref rid="B20-genes-12-00299" ref-type="bibr">20</xref>]. Furthermore, it is known that the exposure of cells to AC EFs significantly enhances intracellular calcium signaling and also alters various cellular functions [<xref rid="B7-genes-12-00299" ref-type="bibr">7</xref>,<xref rid="B21-genes-12-00299" ref-type="bibr">21</xref>,<xref rid="B22-genes-12-00299" ref-type="bibr">22</xref>]. DC is the continuous unidirectional flow of charged particles, which results in electrode polarity. However, on the other hand, AC is the continuous bidirectional flow of charged particles without electrode polarity, resulting in the repetitive stimulation of the target cells [<xref rid="B23-genes-12-00299" ref-type="bibr">23</xref>] and also minimizing electrode corrosion [<xref rid="B24-genes-12-00299" ref-type="bibr">24</xref>]. Further, electric stimulation is known to enhance regeneration-associated gene (RAG) expression and regulate cell behavior by activating many intracellular signaling pathways and shows great promise in disease treatment and wound healing [<xref rid="B25-genes-12-00299" ref-type="bibr">25</xref>,<xref rid="B26-genes-12-00299" ref-type="bibr">26</xref>,<xref rid="B27-genes-12-00299" ref-type="bibr">27</xref>,<xref rid="B28-genes-12-00299" ref-type="bibr">28</xref>]. Since electrical signaling is an active response to injury and it is known that the application of external electrical stimulation modulates the rate of corneal epithelial function, especially at the beginning of the wound healing process, the present work aims to analyze the gene and protein expression profiles following AC EF stimulation. As it is also known that commonly used DC EFs are the cause of most faults [<xref rid="B29-genes-12-00299" ref-type="bibr">29</xref>], resulting in the buildup of ions near electrodes that can eventually nullify the applied EF [<xref rid="B21-genes-12-00299" ref-type="bibr">21</xref>], a novel in vitro system for electric stimulation with AC voltage [<xref rid="B26-genes-12-00299" ref-type="bibr">26</xref>] was used in the present study to investigate the differential expression of genes and proteins in corneal epithelial cells. </p></sec><sec id="sec2-genes-12-00299"><title>2. Materials and Methods</title><p>TPP tissue culture flasks, dishes, and 6- and 12-well plates were obtained from Sigma-Aldrich (Munich, Germany). The QuantiTect Reverse Transcription kit was purchased from Qiagen (Hilden, Germany) and the innuMIX qPCR MasterMix SyGreen was from Analytik-Jena (Jena, Germany). Primers were synthesized from Metabion GmbH (Martinsried, Germany).</p><sec id="sec2dot1-genes-12-00299"><title>2.1. Cell Culture</title><p>Telomerase-immortalized human corneal epithelial cell line [<xref rid="B30-genes-12-00299" ref-type="bibr">30</xref>] (hTCEpi; a kind gift from Prof. J. V. Jester, University of California, Irvine, CA, USA; authenticated and characterized according to ATCC standard protocols) between passages 24 and 30 was used in this present study. The hTCEpi cells were cultured in KGM-Gold&#x02122; growth medium (Lonza, K&#x000f6;ln, Germany). Cells were sub-cultured on T75 tissue culture flasks (Sigma-Aldrich, Munich, Germany), incubated at 37 &#x000b0;C in 5% CO<sub>2</sub>, and passaged every 5&#x02013;7 days.</p></sec><sec id="sec2dot2-genes-12-00299"><title>2.2. Alternating Current (AC) Electric Field (EF) Stimulation</title><p>To study the influence of AC electric fields on hTCEpi cells, an in vitro setup developed by Prof. Bader&#x02019;s group at the Medical University of Rostock, Rostock, Germany, was used [<xref rid="B26-genes-12-00299" ref-type="bibr">26</xref>]. In this system, the electrode setup was modified to perform the EF stimulations in a chamber of a 6-well plate. The pure titanium cylindrical electrodes measuring 14 mm in length and 5 mm in diameter were segregated by a 5 mm-long insulator made up of polyether ether ketone (PEEK). The electrode holders were also made of PEEK and provided a distance of 3 mm between electrodes and the well bottom, thus facilitating growth of the cultured cells below the electrodes. The lid of 6-well plate had pre-drilled holes for the contact titanium rods measuring 35 mm in length. The electrical stimulation was started 14 h after cell seeding. Prior to EF stimulation, the medium was replaced by 4 mL fresh cell culture medium (4.2 mm medium height) without the addition of growth factors. AC EFs were applied continuously for 24 h as a sinusoidal signal of 200 mV and with a frequency of 20 Hz, resulting in a maximum electrical field of 1.4 V/m, as previously described, using a Metrix GX 310 function generator (Metrix Electronics, Hampshire, UK). During stimulation, cells were cultured at 37 &#x000b0;C under 5% CO<sub>2</sub>. For unstimulated control, cells were similarly cultured in a 6-well plate in the presence of the electrode system, however without connecting to the function generator.</p></sec><sec id="sec2dot3-genes-12-00299"><title>2.3. Microarray Hybridization</title><p>After stimulation with AC EFs for 24 h, hTCEpi cells were lysed in RTL Plus buffer, part of the RNeasy Plus Kit (Qiagen, Hilden, Germany), and RNA was extracted according to the manufacturer&#x02019;s protocol. The whole RNA samples were quantified spectrophotometrically (NanoDrop, Thermo Fisher, Darmstadt, Germany) and the integrity was controlled using Agilent Bioanalyzer 2100 with the RNA Nano chip kit (Agilent Genomics, Waldbronn, Germany). RNA integrity number values between 9.0 and 9.8 were achieved and 200 ng was used as the starting material. To perform the differential gene expression profiling, Affymetrix Clariom<sup>TM</sup> S Arrays were used according to the manufacturer&#x02019;s instructions (Affymetrix, St. Clara, CA, USA). The hybridization was carried out overnight at 45&#x000b0;C in the GeneChip<sup>&#x000ae;</sup> Hybridization Oven 645 (Affymetrix). The microarray was scanned using the GeneChip Scanner 3000 (Affymetrix) at 0.7 micron resolution.</p></sec><sec id="sec2dot4-genes-12-00299"><title>2.4. Microarray Data Analysis</title><p>The CEL files generated following the Affymetrix Clariom<sup>TM</sup> S Arrays were analyzed using R [<xref rid="B31-genes-12-00299" ref-type="bibr">31</xref>]. The CEL files were read using the &#x0201c;oligo&#x0201d; R package. Raw data were normalized using the robust multichip algorithm (RMA) method of &#x0201c;oligo&#x0201d; R package. This normalized data were used to generate heatmap and PCA plots. Differential expression analysis was done using &#x0201c;limma&#x0201d; R package [<xref rid="B32-genes-12-00299" ref-type="bibr">32</xref>]. Differentially expressed genes were defined as genes with adjusted <italic>p</italic>-values &#x0003c; 0.05 and absolute log2 foldchanges &#x0003e; 2. GO and KEGG enrichment analysis was performed using the &#x0201c;clusterProfiler&#x0201d; R package [<xref rid="B33-genes-12-00299" ref-type="bibr">33</xref>]. Transcriptome Analysis Console (TAC) software (v.4.0.1.36) and ShinyGO enrichment tool [<xref rid="B34-genes-12-00299" ref-type="bibr">34</xref>] were also used to analyze and graphical representation the data.</p></sec><sec id="sec2dot5-genes-12-00299"><title>2.5. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)</title><p>Total RNA was isolated from cultured hTCEpi cells after 24 h treatment with AC EFs using the NucleoSpin<sup>&#x000ae;</sup> RNA kit (Macherey-Nagel, Berlin, Germany) according to the manufacturer&#x02019;s instructions. Single-stranded cDNA was prepared with 1 &#x000b5;g of total RNA using the QuantiTect Reverse Transcription kit (Qiagen, Hilden, Germany). Intron&#x02013;exon spanning primers were designed from the respective GenBank sequences using VectorNTI software (ThermoFisher Scientific) based on the minimal hairpin, duplex formation, and guanine cytosine composition. A list of primers used in this study is given in <xref rid="genes-12-00299-t001" ref-type="table">Table 1</xref>.</p><p>The synthesized cDNA was then used as a template for qRT-PCR using the innuMIX qPCR MasterMix SyGreen and qTower 2.0 (Analytik Jena, Jena, Germany). The cycling conditions used for amplification were 95 &#x000b0;C for 2 min, 40 cycles of 95 &#x000b0;C for 5 s, and 65 &#x000b0;C for 25 s. Later, the expression of all genes was normalized to the expression of the corresponding housekeeping gene, GAPDH. The relative amounts of target mRNA in the unstimulated control cells and EF-treated cells were analyzed using the &#x00394;&#x00394;<italic>C</italic>t method, as described previously [<xref rid="B35-genes-12-00299" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot6-genes-12-00299"><title>2.6. Antibody MicroarrayAanalysis</title><p>To analyze the differential expression of various proteins in hTCEpi cells following electric stimulation, cells were treated with AC EFs for 24 h as described above. Later, the cells were collected, washed and frozen cell pellets were sent to Sciomics GmbH (Heidelberg, Germany) for further analysis using scioDiscover protein arrays. For each condition, the array was performed in triplicate. Briefly, proteins were extracted, quantified, and labeled with fluorescent dyes. All six samples were analyzed in a dual-color approach using a reference-based design on scioCD antibody microarrays (Sciomics) targeting 1300 proteins. Each antibody is represented in eight replicates on the array. The arrays were blocked with scioBlock (Sciomics) on a Hybstation 4800 instrument (Tecan, Gr&#x000f6;dig, Austria). The resulting data were analyzed using the linear models for the microarray data (LIMMA) package of R-Bioconductor after uploading the median signal intensities for differential protein expression. For normalization, a specialized invariant Lowess method was applied, and for analysis of the samples, a one-factorial linear model was fitted with LIMMA, resulting in a two-sided <italic>t</italic>-test or F-test based on moderated statistics. All presented <italic>p</italic> values were adjusted for multiple testing by controlling the false discovery rate according to Benjamini and Hochberg. Proteins were defined as differential for |logFC| &#x0003e; 0.2 and an adjusted <italic>p</italic>-value of &#x0003c; 0.05. Differences in protein abundance between different samples or sample groups are presented as log-fold changes (logFC) calculated for the basis of 2. In a study comparing samples versus control, a logFC = 1 means that the sample group had on average a 2<sup>1</sup> = 2-fold higher signal as the control group; logFC = &#x02212;1 stands for 2<sup>&#x02212;1</sup> = 1/2 of the signal in the sample as compared to the control group.</p></sec></sec><sec sec-type="results" id="sec3-genes-12-00299"><title>3. Results</title><sec id="sec3dot1-genes-12-00299"><title>3.1. Stimulation of Telomerase-Immortalized Human Corneal Epithelial (hTCEpi) Cells with Alternate Current (AC) Electric Fields (EFs)</title><p>No differences in the morphology of the telomerase-immortalized human corneal epithelial cell line (hTCEpi) were observed during stimulation with AC EFs for 24 h. The distribution of the applied EF strength during AC EF stimulation is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Figure S1</xref>. In addition, EF-stimulated cells maintained a healthy spindle-shaped epithelial morphology and showed growth rate characteristics similar to untreated control cells. Further, no deleterious effects on epithelial cells were observed during AC EF stimulations (<xref ref-type="fig" rid="genes-12-00299-f001">Figure 1</xref>).</p></sec><sec id="sec3dot2-genes-12-00299"><title>3.2. Gene Expession Profiling (GEP) of AC EF-Stimulated hTCEpi Cells</title><p>Since there were no observable morphological differences in hTCEpi cells following EF stimulation, we further proceeded to study the effects of EF stimulation using gene expression analysis. After AC EF treatment of hTCEpi cells for 24 h, cells were washed once with PBS and collected to isolate RNA. Gene level differential expression analysis was performed using Clariom&#x02122; S arrays. Principal component analysis of the RMA normalized microarray data is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Figure S2A</xref>. A clustering heat map of the calibrated samples is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Figure S3A</xref>, whereas a volcano plot of the differentially expressed genes is depicted in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Figure S3B</xref>. Of the 21,448 genes analyzed, only 5.35% of the genes were found to be differentially expressed (556 genes were upregulated and 591 genes were downregulated) after stimulation of hTCEpi cells with AC EFs compared to the control untreated cells (<xref ref-type="fig" rid="genes-12-00299-f002">Figure 2</xref>).</p><p>Gene Ontology analysis using the STRING database of the 1147 genes that are upregulated and downregulated upon stimulation with AC EFs revealed activation of biological processes that are predominantly responsive to external, chemical, and cytokine stimuli, which in turn subsequently leading to the activation of various pathways, which are shown in <xref rid="genes-12-00299-t002" ref-type="table">Table 2</xref>. A list of genes that are upregulated and downregulated after treatment with AC EFs is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Table S1</xref>.</p></sec><sec id="sec3dot3-genes-12-00299"><title>3.3. Validation of Trancriptome Analysis Data by qRT-PCR</title><p>To further validate the transcriptome analysis data obtained after treatment of hTCEpi cells with AC EFs, we performed qRT-PCR of various transcripts using RNA isolated from stimulated cells. All the analyzed transcripts showed a similar expression profile as was observed in the gene array analysis (<xref ref-type="fig" rid="genes-12-00299-f003">Figure 3</xref>).</p></sec><sec id="sec3dot4-genes-12-00299"><title>3.4. Antibody Microarray Analysis of Differentially Expressed Proteins in hTCEpi Cells</title><p>Antibody microarrays were performed using scioDiscover Protein Expression Array (Sciomics GmbH, Germany) to identify putative alterations in hTCEpi cells at the protein level after treatment with AC EFs for 24 h (<xref ref-type="fig" rid="genes-12-00299-f004">Figure 4</xref>). Regarding the antibody array, hierarchical clustering of the protein extracts based on differentially expressed proteins is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Figure S2B</xref>. Identification of the functional associations between proteins on a genome-wide scale and construction of a protein&#x02013;protein interaction (PPI) networks for analysis was performed using the STRING database (Available online: <uri xlink:href="https://string-db.org/">https://string-db.org/</uri> (accessed on 14 December 2020)). Analysis of the protein array data revealed that the treatment of cells with AC EFs altered the expression of various protein products and the resulting heatmap of the protein differential expression is depicted in <xref ref-type="fig" rid="genes-12-00299-f005">Figure 5</xref>. A list of proteins that are upregulated and downregulated after treatment with AC EFs is shown in <xref ref-type="app" rid="app1-genes-12-00299">Supplementary Table S2</xref>. The PPI network consisted of 173 nodes interacting through 1261 edges. Of all the differentially abundant proteins, 132 proteins displayed positive logFC values &#x0003e; 0.2 in AC EF-stimulated cells, whereas 63 proteins showed logFC values &#x0003e; 0.2 in untreated control cells.</p><p>Analysis of the abundant proteins using the STRING database revealed activation of various diverse cellular signaling pathways in which TNF, MAPK, IL17, and PI3K-Akt signaling pathways were significantly impacted (<xref rid="genes-12-00299-t003" ref-type="table">Table 3</xref>).</p><p>Further, we also performed ShinyGO [<xref rid="B34-genes-12-00299" ref-type="bibr">34</xref>] Gene Ontology enrichment analysis using differentially expressed up- and downregulated genes and proteins based on the data from both arrays. Graphical representations of enriched biological processes and pathways are shown in <xref ref-type="fig" rid="genes-12-00299-f006">Figure 6</xref>, <xref ref-type="fig" rid="genes-12-00299-f007">Figure 7</xref>, <xref ref-type="fig" rid="genes-12-00299-f008">Figure 8</xref> and <xref ref-type="fig" rid="genes-12-00299-f009">Figure 9</xref>. We observed enrichment of 9 similar biological processes and 9 similar pathways in both arrays, confirming activation of similar cellular events at both the gene and protein levels following AC EF stimulation. Further, in comparison to the gene array data, protein array data showed enrichment of more activated pathways through several interconnecting networks.</p></sec></sec><sec sec-type="discussion" id="sec4-genes-12-00299"><title>4. Discussion and Conclusions</title><p>In cells, intrinsic endogenous DC EFs serve as morphogenetic cues and are necessary for several important cellular responses, including activation of multiple signaling pathways, cell migration, nerve regeneration, and wound healing [<xref rid="B16-genes-12-00299" ref-type="bibr">16</xref>,<xref rid="B36-genes-12-00299" ref-type="bibr">36</xref>,<xref rid="B37-genes-12-00299" ref-type="bibr">37</xref>]. Further, DC EFs are known to induce asymmetry in the distribution, arrangement of membrane receptors, and activate intracellular signaling cascades in the cathode-facing side, resulting in the growth of neurites in the cathode direction [<xref rid="B20-genes-12-00299" ref-type="bibr">20</xref>,<xref rid="B38-genes-12-00299" ref-type="bibr">38</xref>,<xref rid="B39-genes-12-00299" ref-type="bibr">39</xref>]. In contrast, in vitro stimulation with small AC EFs has no effect on neural progenitor cell alignment, viability, differentiation, or proliferation, similar to control unstimulated cells [<xref rid="B18-genes-12-00299" ref-type="bibr">18</xref>]. Additionally, an increase in AC EF frequency influences neural stem cell viability and differentiation by slowing down their maturation [<xref rid="B40-genes-12-00299" ref-type="bibr">40</xref>], suggesting a lineage control role of AC EFs on neural cells [<xref rid="B20-genes-12-00299" ref-type="bibr">20</xref>]. Based on these observations and due to the presence of the highest number of free nerve endings in the cornea, along with the existence of stem cells in the corneal limbus, it is also necessary to study the consequences of the application of AC EFs on corneal cells. Since epithelial cells are mainly accountable for the corneal wound healing process and as the effects of external AC EFs in modulating the epithelial cell function is presently not known, this study was carried out to understand the influence of external AC EF stimulation on corneal epithelial cell function. </p><p>Upon stimulation with AC EFs, similar to PC12 cells [<xref rid="B41-genes-12-00299" ref-type="bibr">41</xref>], no significant differences in corneal epithelial cell viability or proliferation were observed. All of the literature reports so far used constant electric stimulation to study the effects of external EF applications on corneal epithelial cells and showed increased cell division, directional migration [<xref rid="B42-genes-12-00299" ref-type="bibr">42</xref>], regeneration [<xref rid="B43-genes-12-00299" ref-type="bibr">43</xref>], and wound healing [<xref rid="B1-genes-12-00299" ref-type="bibr">1</xref>]. MMPs play a crucial role in corneal wound healing [<xref rid="B44-genes-12-00299" ref-type="bibr">44</xref>] and corneal epithelial cells show enhanced MMP3 and unaltered MMP2 and MMP9 expression following DC EF stimulation [<xref rid="B45-genes-12-00299" ref-type="bibr">45</xref>]. Our gene array data also showed increased expression of MMP1 (48-fold), MMP10 (20-fold), and MMP9 (4-fold) and decreased expression of MMP2, MMP13, and MMP19 (2-fold each), whereas protein array data showed upregulation of MMPs 1, 7, 10, and 12. The application of DC EFs is known to significantly increase the activation of AKT and impact the PI3K/AKT pathway, which plays an important role in cell survival, growth, migration, and metabolism [<xref rid="B46-genes-12-00299" ref-type="bibr">46</xref>]. Further, DC-induced activation of the PI3K/AKT pathway was also reported in different cell types, including neural progenitor cells [<xref rid="B47-genes-12-00299" ref-type="bibr">47</xref>], Schwann cells [<xref rid="B48-genes-12-00299" ref-type="bibr">48</xref>], and human umbilical vein endothelial cells (HUVEC) [<xref rid="B49-genes-12-00299" ref-type="bibr">49</xref>], as well as in ocular cells, including the corneal epithelium [<xref rid="B6-genes-12-00299" ref-type="bibr">6</xref>,<xref rid="B50-genes-12-00299" ref-type="bibr">50</xref>]. Activation of the MAPK signaling pathway is also reported through the application of EFs in neuronal cells [<xref rid="B51-genes-12-00299" ref-type="bibr">51</xref>,<xref rid="B52-genes-12-00299" ref-type="bibr">52</xref>], fibroblasts, HUVEC [<xref rid="B53-genes-12-00299" ref-type="bibr">53</xref>], and corneal epithelial cells [<xref rid="B6-genes-12-00299" ref-type="bibr">6</xref>]. Likewise, we also observed activation of PI3K/AKT and MAPK signaling pathways, along with other interconnected pathways, including T cell receptor signaling, Toll-like receptor signaling, TNF signaling, IL-17 signaling, FoxO signaling, and focal adhesion pathways, upon stimulation of corneal epithelial cells with oscillating EFs. In addition, electric stimulation upregulates expression of RAGs, increases neurotrophin signaling, accelerates axon guidance and outgrowth during peripheral nerve regeneration [<xref rid="B25-genes-12-00299" ref-type="bibr">25</xref>,<xref rid="B54-genes-12-00299" ref-type="bibr">54</xref>,<xref rid="B55-genes-12-00299" ref-type="bibr">55</xref>,<xref rid="B56-genes-12-00299" ref-type="bibr">56</xref>,<xref rid="B57-genes-12-00299" ref-type="bibr">57</xref>], and is also known to activate axon guidance, along with various metabolic and signaling pathways that play crucial interconnecting roles during axon regeneration [<xref rid="B17-genes-12-00299" ref-type="bibr">17</xref>,<xref rid="B57-genes-12-00299" ref-type="bibr">57</xref>,<xref rid="B58-genes-12-00299" ref-type="bibr">58</xref>,<xref rid="B59-genes-12-00299" ref-type="bibr">59</xref>]. Accordingly, our gene array data analysis also showed activation of similar pathways during AC EF stimulation of corneal epithelial cells. </p><p>Generally, it is well known that following cell-specific stimulation, the resulting gene expression profiles measured using gene arrays are inadequate to predict protein expression and subsequent functional outcomes on a genomic scale, since interrelationships between mRNA and protein levels vary greatly due to post-transcriptional mechanisms, as well as post-translational modifications. Influencing factors such as the mRNA transcription rate, stability, translational regulation, along with protein activity and degradation serve as limiting factors and controlling elements in a given cell at the physiological level when interpreting the after effects of that cell-specific stimulus [<xref rid="B60-genes-12-00299" ref-type="bibr">60</xref>,<xref rid="B61-genes-12-00299" ref-type="bibr">61</xref>,<xref rid="B62-genes-12-00299" ref-type="bibr">62</xref>]. However, in our study, comparison of the expression profiles of certain genes and their corresponding protein abundance levels showed similar patterns following stimulation with AC EFs. Accordingly, enriched pathways and processes following analysis of the gene and antibody array data using the STRING database also showed consistent enrichment of similar biological processes and signaling pathways, further highlighting the balanced, steady state of the epithelial cells during AC EF stimulation [<xref rid="B62-genes-12-00299" ref-type="bibr">62</xref>]. Additionally, antibody array data showed enrichment of various interconnecting signaling events due to the involvement of similar molecules in multiple pathways, which was not observed during gene array data analysis. Since electric stimulation is considered as a master regulator of regeneration-associated cellular networks [<xref rid="B27-genes-12-00299" ref-type="bibr">27</xref>,<xref rid="B63-genes-12-00299" ref-type="bibr">63</xref>], stimulation with AC EFs also switches on several intracellular pathways, and thus can be implemented, upon further testing and validation at shorter time points, as a potential therapeutic approach for corneal tissue regeneration. </p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Colette Leyh for her technical skills and expertise. We also thank James V. Jester, University of California, USA, for providing immortalized hTCEpi cells, as well as Rainer Bader&#x02019;s group, Department of Orthopedics, Rostock University Medical Center, for assisting in our AC EF stimulation and qRT-PCR experiments. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Universit&#x000e4;t Rostock/Universit&#x000e4;tsmedizin Rostock within the funding programme Open Access Publishing.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-genes-12-00299"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2073-4425/12/2/299/s1">https://www.mdpi.com/2073-4425/12/2/299/s1</uri>: Figure S1: Distribution of applied AC EF strength in a 6-well plate during hTCEpi cell stimulation (electric potential: 200 mV; frequency: 20 Hz; wave form). Figure S2: Analysis of the gene and protein array data: (A) principal component analysis of the RMA-normalized microarray data; (B) hierarchical clustering of the protein extracts based on differentially expressed proteins. Figure S3: Analysis of the gene array data: (A) clustering heat map of the calibrated samples; (B) volcano plot of the differentially expressed genes. Table S1: Gene array data. Table S2: Antibody array data.</p><supplementary-material content-type="local-data" id="genes-12-00299-s001"><media xlink:href="genes-12-00299-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, B.S.K., and O.S.; methodology, B.S.K., J.Z., and D.K.; software, N.K.S., B.S.K., and J.D.; validation, N.K.S., B.S.K., D.K., and J.D.; formal analysis, N.K.S., B.S.K., and J.D; investigation, B.S.K.; resources, B.S.K., O.S., and R.B.; data curation, B.S.K. and D.K.; writing&#x02014;original draft preparation, B.S.K.; writing&#x02014;review and editing, B.S.K. and O.S.; visualization, B.S.K.; supervision, O.S. and R.B.; project administration, B.S.K., O.S., and R.B.; funding acquisition, B.S.K., and O.S.; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>Deutsche Forschungsgemeinschaft (DFG)-(KO-4979/1-1); Department of Ophthalmology, Rostock University Medical Center, Rostock; Hyderabad Eye Research Foundation (HERF).</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data is contained within the supplementary material.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. </p></notes><ref-list><title>References</title><ref id="B1-genes-12-00299"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>B.J.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>The Electrical Response to Injury: Molecular Mechanisms and Wound Healing</article-title><source>Adv. Wound Care</source><year>2014</year><volume>3</volume><fpage>184</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1089/wound.2013.0442</pub-id></element-citation></ref><ref id="B2-genes-12-00299"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>A.C.</given-names></name><name><surname>Reid</surname><given-names>B.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Mannis</surname><given-names>M.J.</given-names></name><name><surname>Schwab</surname><given-names>I.R.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Ionic Components of Electric Current at Rat Corneal Wounds</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e17411</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017411</pub-id><pub-id pub-id-type="pmid">21364900</pub-id></element-citation></ref><ref id="B3-genes-12-00299"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuccitelli</surname><given-names>R.</given-names></name></person-group><article-title>Physiological Electric Fields can Influence Cell Motility, Growth, and Polarity</article-title><source>Adv. Mol. Cell Biol.</source><year>1988</year><volume>2</volume><fpage>213</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/S1569-2558(08)60435-X</pub-id></element-citation></ref><ref id="B4-genes-12-00299"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrier</surname><given-names>J.</given-names></name><name><surname>Ross</surname><given-names>S.M.</given-names></name><name><surname>Kanehisa</surname><given-names>J.</given-names></name><name><surname>Aubin</surname><given-names>J.E.</given-names></name></person-group><article-title>Osteoclasts and osteoblasts migrate in opposite directions in response to a constant electrical field</article-title><source>J. Cell. Physiol.</source><year>1986</year><volume>129</volume><fpage>283</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1002/jcp.1041290303</pub-id><pub-id pub-id-type="pmid">3782308</pub-id></element-citation></ref><ref id="B5-genes-12-00299"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>B.</given-names></name><name><surname>Graue-Hernandez</surname><given-names>E.O.</given-names></name><name><surname>Mannis</surname><given-names>M.J.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Modulating Endogenous Electric Currents in Human Corneal Wounds&#x02014;A Novel Approach of Bioelectric Stimulation Without Electrodes</article-title><source>Cornea</source><year>2011</year><volume>30</volume><fpage>338</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1097/ICO.0b013e3181f7f2de</pub-id><?supplied-pmid 21099404?><pub-id pub-id-type="pmid">21099404</pub-id></element-citation></ref><ref id="B6-genes-12-00299"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Chalmers</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Vieira</surname><given-names>A.C.</given-names></name><name><surname>Mannis</surname><given-names>M.</given-names></name><name><surname>Reid</surname><given-names>B.</given-names></name></person-group><article-title>Electrical signaling in control of ocular cell behaviors</article-title><source>Prog. Retin. Eye Res.</source><year>2012</year><volume>31</volume><fpage>65</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2011.10.001</pub-id><?supplied-pmid 22020127?><pub-id pub-id-type="pmid">22020127</pub-id></element-citation></ref><ref id="B7-genes-12-00299"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Mehta</surname><given-names>A.S.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Biomedical applications of electrical stimulation</article-title><source>Cell. Mol. Life Sci.</source><year>2020</year><volume>77</volume><fpage>2681</fpage><lpage>2699</lpage><pub-id pub-id-type="doi">10.1007/s00018-019-03446-1</pub-id><pub-id pub-id-type="pmid">31974658</pub-id></element-citation></ref><ref id="B8-genes-12-00299"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soong</surname><given-names>H.K.</given-names></name><name><surname>Parkinson</surname><given-names>W.C.</given-names></name><name><surname>Bafna</surname><given-names>S.</given-names></name><name><surname>Sulik</surname><given-names>G.L.</given-names></name><name><surname>Huang</surname><given-names>S.C.</given-names></name></person-group><article-title>Movements of cultured corneal epithelial cells and stromal fibroblasts in electric fields</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>1990</year><volume>31</volume><fpage>2278</fpage><lpage>2282</lpage><pub-id pub-id-type="pmid">2242993</pub-id></element-citation></ref><ref id="B9-genes-12-00299"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Forrester</surname><given-names>J.V.</given-names></name><name><surname>McCaig</surname><given-names>C.D.</given-names></name></person-group><article-title>A small, physiological electric field orients cell division</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>4942</fpage><lpage>4946</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.9.4942</pub-id><?supplied-pmid 10220398?><pub-id pub-id-type="pmid">10220398</pub-id></element-citation></ref><ref id="B10-genes-12-00299"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Dick</surname><given-names>A.</given-names></name><name><surname>Forrester</surname><given-names>J.V.</given-names></name><name><surname>McCaig</surname><given-names>C.D.</given-names></name></person-group><article-title>Electric Field&#x02013;directed Cell Motility Involves Up-regulated Expression and Asymmetric Redistribution of the Epidermal Growth Factor Receptors and Is Enhanced by Fibronectin and Laminin</article-title><source>Mol. Biol. Cell</source><year>1999</year><volume>10</volume><fpage>1259</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1091/mbc.10.4.1259</pub-id><pub-id pub-id-type="pmid">10198071</pub-id></element-citation></ref><ref id="B11-genes-12-00299"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Agius-Fernandez</surname><given-names>A.</given-names></name><name><surname>Forrester</surname><given-names>J.V.</given-names></name><name><surname>McCaig</surname><given-names>C.D.</given-names></name></person-group><article-title>Orientation and directed migration of cultured corneal epithelial cells in small electric fields are serum dependent</article-title><source>J. Cell Sci.</source><year>1996</year><volume>109</volume><fpage>1405</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">8799828</pub-id></element-citation></ref><ref id="B12-genes-12-00299"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>McCaig</surname><given-names>C.D.</given-names></name><name><surname>Agius-Fernandez</surname><given-names>A.</given-names></name><name><surname>Forrester</surname><given-names>J.V.</given-names></name><name><surname>Araki-Sasaki</surname><given-names>K.</given-names></name></person-group><article-title>Human corneal epithelial cells reorient and migrate cathodally in a small applied electric field</article-title><source>Curr. Eye Res.</source><year>1997</year><volume>16</volume><fpage>973</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1076/ceyr.16.10.973.9014</pub-id><?supplied-pmid 9330848?><pub-id pub-id-type="pmid">9330848</pub-id></element-citation></ref><ref id="B13-genes-12-00299"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesia</surname><given-names>D.D.S.</given-names></name><name><surname>Vanable</surname><given-names>J.W.</given-names></name></person-group><article-title>Endogenous lateral electric fields around bovine corneal lesions are necessary for and can enhance normal rates of wound healing</article-title><source>Wound Repair Regen.</source><year>1998</year><volume>6</volume><fpage>531</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1046/j.1524-475X.1998.60606.x</pub-id><pub-id pub-id-type="pmid">9893173</pub-id></element-citation></ref><ref id="B14-genes-12-00299"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>McCaig</surname><given-names>C.D.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Wound healing in rat cornea: The role of electric currents</article-title><source>FASEB J.</source><year>2004</year><volume>19</volume><fpage>379</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1096/fj.04-2325com</pub-id></element-citation></ref><ref id="B15-genes-12-00299"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>K.-I.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Inoue</surname><given-names>Y.</given-names></name><name><surname>Hata</surname><given-names>Y.</given-names></name></person-group><article-title>Neuroprotective Effect of Transcorneal Electrical Stimulation on the Acute Phase of Optic Nerve Injury</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2007</year><volume>48</volume><fpage>2356</fpage><lpage>2361</lpage><pub-id pub-id-type="doi">10.1167/iovs.06-1329</pub-id><pub-id pub-id-type="pmid">17460302</pub-id></element-citation></ref><ref id="B16-genes-12-00299"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Forrester</surname><given-names>J.</given-names></name><name><surname>McCaig</surname><given-names>C.</given-names></name></person-group><article-title>Nerve regeneration and wound healing are stimulated and directed by an endogenous electrical field in vivo</article-title><source>J. Cell Sci.</source><year>2004</year><volume>117</volume><fpage>4681</fpage><lpage>4690</lpage><pub-id pub-id-type="doi">10.1242/jcs.01341</pub-id><pub-id pub-id-type="pmid">15371524</pub-id></element-citation></ref><ref id="B17-genes-12-00299"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>Y.</given-names></name><name><surname>Sammons</surname><given-names>V.</given-names></name><name><surname>Forden</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>G.F.</given-names></name><name><surname>Kipp</surname><given-names>A.</given-names></name><name><surname>Girgulis</surname><given-names>J.</given-names></name><name><surname>Mishra</surname><given-names>T.</given-names></name><name><surname>de Villers Alant</surname><given-names>J.D.</given-names></name><name><surname>Midha</surname><given-names>R.</given-names></name></person-group><article-title>Brief Electrical Stimulation Promotes Nerve Regeneration Following Experimental In-Continuity Nerve Injury</article-title><source>Neurosurgery</source><year>2018</year><volume>85</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1093/neuros/nyy221</pub-id><?supplied-pmid 29893910?><pub-id pub-id-type="pmid">29893910</pub-id></element-citation></ref><ref id="B18-genes-12-00299"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariza</surname><given-names>C.A.</given-names></name><name><surname>Fleury</surname><given-names>A.T.</given-names></name><name><surname>Tormos</surname><given-names>C.J.</given-names></name><name><surname>Petruk</surname><given-names>V.</given-names></name><name><surname>Chawla</surname><given-names>S.</given-names></name><name><surname>Oh</surname><given-names>J.</given-names></name><name><surname>Sakaguchi</surname><given-names>D.S.</given-names></name><name><surname>Mallapragada</surname><given-names>S.K.</given-names></name></person-group><article-title>The Influence of Electric Fields on Hippocampal Neural Progenitor Cells</article-title><source>Stem Cell Rev. Rep.</source><year>2010</year><volume>6</volume><fpage>585</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1007/s12015-010-9171-0</pub-id><?supplied-pmid 20665129?><pub-id pub-id-type="pmid">20665129</pub-id></element-citation></ref><ref id="B19-genes-12-00299"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biasiotta</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Arcangelo</surname><given-names>D.</given-names></name><name><surname>Passarelli</surname><given-names>F.</given-names></name><name><surname>Nicodemi</surname><given-names>E.M.</given-names></name><name><surname>Facchiano</surname><given-names>A.</given-names></name></person-group><article-title>Ion channels expression and function are strongly modified in solid tumors and vascular malformations</article-title><source>J. Transl. Med.</source><year>2016</year><volume>14</volume><fpage>285</fpage><pub-id pub-id-type="doi">10.1186/s12967-016-1038-y</pub-id><?supplied-pmid 27716384?><pub-id pub-id-type="pmid">27716384</pub-id></element-citation></ref><ref id="B20-genes-12-00299"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>J.-H.</given-names></name><name><surname>McCullen</surname><given-names>S.D.</given-names></name><name><surname>Piedrahita</surname><given-names>J.A.</given-names></name><name><surname>Loboa</surname><given-names>E.G.</given-names></name><name><surname>Olby</surname><given-names>N.J.</given-names></name></person-group><article-title>Alternating Current Electric Fields of Varying Frequencies: Effects on Proliferation and Differentiation of Porcine Neural Progenitor Cells</article-title><source>Cell. Reprogramming</source><year>2013</year><volume>15</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1089/cell.2013.0001</pub-id></element-citation></ref><ref id="B21-genes-12-00299"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCullen</surname><given-names>S.D.</given-names></name><name><surname>McQuilling</surname><given-names>J.P.</given-names></name><name><surname>Grossfeld</surname><given-names>R.M.</given-names></name><name><surname>Lubischer</surname><given-names>J.L.</given-names></name><name><surname>Clarke</surname><given-names>L.I.</given-names></name><name><surname>Loboa</surname><given-names>E.G.</given-names></name></person-group><article-title>Application of Low-Frequency Alternating Current Electric Fields Via Interdigitated Electrodes: Effects on Cellular Viability, Cytoplasmic Calcium, and Osteogenic Differentiation of Human Adipose-Derived Stem Cells</article-title><source>Tissue Eng. Part C Methods</source><year>2010</year><volume>16</volume><fpage>1377</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1089/ten.tec.2009.0751</pub-id><pub-id pub-id-type="pmid">20367249</pub-id></element-citation></ref><ref id="B22-genes-12-00299"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahm</surname><given-names>F.</given-names></name><name><surname>Ziebart</surname><given-names>J.</given-names></name><name><surname>Jonitz-Heincke</surname><given-names>A.</given-names></name><name><surname>Hansmann</surname><given-names>D.</given-names></name><name><surname>Dauben</surname><given-names>T.</given-names></name><name><surname>Bader</surname><given-names>R.</given-names></name></person-group><article-title>Alternating Electric Fields Modify the Function of Human Osteoblasts Growing on and in the Surroundings of Titanium Electrodes</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>6944</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21186944</pub-id><?supplied-pmid 32971771?><pub-id pub-id-type="pmid">32971771</pub-id></element-citation></ref><ref id="B23-genes-12-00299"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>R.M.</given-names></name><name><surname>Geddes</surname><given-names>L.A.</given-names></name></person-group><article-title>Conduction of Electrical Current to and Through the Human Body: A Review</article-title><source>Eplasty</source><year>2009</year><volume>9</volume><fpage>44</fpage></element-citation></ref><ref id="B24-genes-12-00299"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Neville</surname><given-names>A.</given-names></name><name><surname>Dowson</surname><given-names>D.</given-names></name></person-group><article-title>Biotribocorrosion&#x02014;an appraisal of the time dependence of wear and corrosion interactions: I. The role of corrosion</article-title><source>J. Phys. D Appl. Phys.</source><year>2006</year><volume>39</volume><fpage>3200</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.1088/0022-3727/39/15/S10</pub-id></element-citation></ref><ref id="B25-genes-12-00299"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Majed</surname><given-names>A.A.</given-names></name><name><surname>Tam</surname><given-names>S.L.</given-names></name><name><surname>Gordon</surname><given-names>T.</given-names></name></person-group><article-title>Electrical Stimulation Accelerates and Enhances Expression of Regeneration-Associated Genes in Regenerating Rat Femoral Motoneurons</article-title><source>Cell. Mol. Neurobiol.</source><year>2004</year><volume>24</volume><fpage>379</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1023/B:CEMN.0000022770.66463.f7</pub-id><pub-id pub-id-type="pmid">15206821</pub-id></element-citation></ref><ref id="B26-genes-12-00299"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiemer</surname><given-names>B.</given-names></name><name><surname>Krogull</surname><given-names>M.</given-names></name><name><surname>Bender</surname><given-names>T.</given-names></name><name><surname>Ziebart</surname><given-names>J.</given-names></name><name><surname>Krueger</surname><given-names>S.</given-names></name><name><surname>Bader</surname><given-names>R.</given-names></name><name><surname>Jonitz-Heincke</surname><given-names>A.</given-names></name></person-group><article-title>Effect of electric stimulation on human chondrocytes and mesenchymal stem cells under normoxia and hypoxia</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>18</volume><fpage>2133</fpage><lpage>2141</lpage><pub-id pub-id-type="doi">10.3892/mmr.2018.9174</pub-id><pub-id pub-id-type="pmid">29916541</pub-id></element-citation></ref><ref id="B27-genes-12-00299"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>I.-S.</given-names></name></person-group><article-title>Electrical stimulation as a novel tool for regulating cell behavior in tissue engineering</article-title><source>Biomater. Res.</source><year>2019</year><volume>23</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/s40824-019-0176-8</pub-id><?supplied-pmid 31844552?><pub-id pub-id-type="pmid">30788137</pub-id></element-citation></ref><ref id="B28-genes-12-00299"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>M.</given-names></name><name><surname>Alonso-Rasgado</surname><given-names>T.</given-names></name><name><surname>Baguneid</surname><given-names>M.</given-names></name><name><surname>Bayat</surname><given-names>A.</given-names></name></person-group><article-title>The efficacy of electrical stimulation in lower extremity cutaneous wound healing: A systematic review</article-title><source>Exp. Dermatol.</source><year>2017</year><volume>26</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1111/exd.13179</pub-id><?supplied-pmid 27576070?><pub-id pub-id-type="pmid">27576070</pub-id></element-citation></ref><ref id="B29-genes-12-00299"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Souffrant</surname><given-names>R.</given-names></name><name><surname>Kluess</surname><given-names>D.</given-names></name><name><surname>Ellenrieder</surname><given-names>M.</given-names></name><name><surname>Mittelmeier</surname><given-names>W.</given-names></name><name><surname>Van Rienen</surname><given-names>U.</given-names></name><name><surname>Bader</surname><given-names>R.</given-names></name></person-group><article-title>Evaluation of electric field distribution in electromagnetic stimulation of human femoral head</article-title><source>Bioelectromagnetics</source><year>2014</year><volume>35</volume><fpage>547</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1002/bem.21879</pub-id><pub-id pub-id-type="pmid">25251424</pub-id></element-citation></ref><ref id="B30-genes-12-00299"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>D.M.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Fisher</surname><given-names>S.</given-names></name><name><surname>Pearce</surname><given-names>V.P.</given-names></name><name><surname>Shay</surname><given-names>J.W.</given-names></name><name><surname>Wright</surname><given-names>W.E.</given-names></name><name><surname>Cavanagh</surname><given-names>H.D.</given-names></name><name><surname>Jester</surname><given-names>J.V.</given-names></name></person-group><article-title>Characterization of Growth and Differentiation in a Telomerase-Immortalized Human Corneal Epithelial Cell Line</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2005</year><volume>46</volume><fpage>470</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1167/iovs.04-0528</pub-id><pub-id pub-id-type="pmid">15671271</pub-id></element-citation></ref><ref id="B31-genes-12-00299"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>B.S.</given-names></name><name><surname>Irizarry</surname><given-names>R.A.</given-names></name></person-group><article-title>A framework for oligonucleotide microarray preprocessing</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>2363</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq431</pub-id><pub-id pub-id-type="pmid">20688976</pub-id></element-citation></ref><ref id="B32-genes-12-00299"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>M.E.</given-names></name><name><surname>Phipson</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Law</surname><given-names>C.W.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name></person-group><article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>e47</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="B33-genes-12-00299"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.-G.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>Q.-Y.</given-names></name></person-group><article-title>clusterProfiler: An R Package for Comparing Biological Themes Among Gene Clusters</article-title><source>OMICS J. Integr. Biol.</source><year>2012</year><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><?supplied-pmid 22455463?><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="B34-genes-12-00299"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>S.X.</given-names></name><name><surname>Jung</surname><given-names>D.</given-names></name><name><surname>Yao</surname><given-names>R.</given-names></name></person-group><article-title>ShinyGO: A graphical gene-set enrichment tool for animals and plants</article-title><source>Bioinformatics</source><year>2020</year><volume>36</volume><fpage>2628</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz931</pub-id><?supplied-pmid 31882993?><pub-id pub-id-type="pmid">31882993</pub-id></element-citation></ref><ref id="B35-genes-12-00299"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-&#x00394;&#x00394;CT</sup> Method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="B36-genes-12-00299"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>B.R.</given-names></name><name><surname>Nuccitelli</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Non-invasive measurement of bioelectric currents with a vibrating probe</article-title><source>Nat. Protoc.</source><year>2007</year><volume>2</volume><fpage>661</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.91</pub-id><?supplied-pmid 17406628?><pub-id pub-id-type="pmid">17406628</pub-id></element-citation></ref><ref id="B37-genes-12-00299"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>G.</given-names></name><name><surname>Tai</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Electrically stimulated cell migration and its contribution to wound healing</article-title><source>Burn. Trauma</source><year>2018</year><volume>6</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/s41038-018-0123-2</pub-id></element-citation></ref><ref id="B38-genes-12-00299"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaig</surname><given-names>C.D.</given-names></name></person-group><article-title>Dynamic aspects of amphibian neurite growth and the effects of an applied electric field</article-title><source>J. Physiol.</source><year>1986</year><volume>375</volume><fpage>55</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1986.sp016105</pub-id><pub-id pub-id-type="pmid">3795068</pub-id></element-citation></ref><ref id="B39-genes-12-00299"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Shanley</surname><given-names>L.</given-names></name><name><surname>McCaig</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Small applied electric fields guide migration of hippocampal neurons</article-title><source>J. Cell. Physiol.</source><year>2008</year><volume>216</volume><fpage>527</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1002/jcp.21431</pub-id><?supplied-pmid 18393356?><pub-id pub-id-type="pmid">18393356</pub-id></element-citation></ref><ref id="B40-genes-12-00299"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos</surname><given-names>M.A.</given-names></name><name><surname>Cicerone</surname><given-names>M.T.</given-names></name></person-group><article-title>Alternating current electric field effects on neural stem cell viability and differentiation</article-title><source>Biotechnol. Prog.</source><year>2010</year><volume>26</volume><fpage>664</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1002/btpr.389</pub-id><pub-id pub-id-type="pmid">20205161</pub-id></element-citation></ref><ref id="B41-genes-12-00299"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Moon</surname><given-names>H.T.</given-names></name><name><surname>Woo</surname><given-names>D.G.</given-names></name><name><surname>Na Yang</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>K.-H.</given-names></name></person-group><article-title>Electrical Pulsed Stimulation of Surfaces Homogeneously Coated with Gold Nanoparticles to Induce Neurite Outgrowth of PC12 Cells</article-title><source>Langmuir</source><year>2009</year><volume>25</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1021/la8025683</pub-id><pub-id pub-id-type="pmid">19049400</pub-id></element-citation></ref><ref id="B42-genes-12-00299"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farboudab</surname><given-names>B.</given-names></name><name><surname>Nuccitellia</surname><given-names>R.</given-names></name><name><surname>Schwab</surname><given-names>I.R.</given-names></name><name><surname>Isseroff</surname><given-names>R.</given-names></name></person-group><article-title>DC Electric Fields Induce Rapid Directional Migration in Cultured Human Corneal Epithelial Cells</article-title><source>Exp. Eye Res.</source><year>2000</year><volume>70</volume><fpage>667</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1006/exer.2000.0830</pub-id><?supplied-pmid 10870525?><pub-id pub-id-type="pmid">10870525</pub-id></element-citation></ref><ref id="B43-genes-12-00299"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>E.-T.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Regulation of tissue repair and regeneration by electric fields</article-title><source>Chin. J. Traumatol.</source><year>2010</year><volume>13</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20109370</pub-id></element-citation></ref><ref id="B44-genes-12-00299"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulholland</surname><given-names>B.</given-names></name><name><surname>Tuft</surname><given-names>S.J.</given-names></name><name><surname>Khaw</surname><given-names>P.T.</given-names></name></person-group><article-title>Matrix metalloproteinase distribution during early corneal wound healing</article-title><source>Eye</source><year>2004</year><volume>19</volume><fpage>584</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1038/sj.eye.6701557</pub-id><?supplied-pmid 15332107?><pub-id pub-id-type="pmid">15332107</pub-id></element-citation></ref><ref id="B45-genes-12-00299"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Raghunathan</surname><given-names>V.K.</given-names></name><name><surname>Reid</surname><given-names>B.</given-names></name><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Diaz</surname><given-names>R.C.</given-names></name><name><surname>Russell</surname><given-names>P.</given-names></name><name><surname>Murphy</surname><given-names>C.J.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group><article-title>Biomimetic stochastic to-pography and electric fields synergistically enhance directional migration of corneal epithelial cells in a mmp-3-dependent manner</article-title><source>Acta Biomater.</source><year>2015</year><volume>12</volume><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2014.10.007</pub-id><pub-id pub-id-type="pmid">25311684</pub-id></element-citation></ref><ref id="B46-genes-12-00299"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Han</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>A</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Applied electric fields suppress osimertinib-induced cytotoxicity via inhibiting FOXO3a nuclear translocation through AKT activation</article-title><source>Carcinogenesis</source><year>2019</year><volume>41</volume><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgz150</pub-id></element-citation></ref><ref id="B47-genes-12-00299"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Arocena</surname><given-names>M.</given-names></name><name><surname>Penninger</surname><given-names>J.</given-names></name><name><surname>Gage</surname><given-names>F.H.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name></person-group><article-title>PI3K mediated electrotaxis of embryonic and adult neural progenitor cells in the presence of growth factors</article-title><source>Exp. Neurol.</source><year>2011</year><volume>227</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2010.11.002</pub-id><pub-id pub-id-type="pmid">21092738</pub-id></element-citation></ref><ref id="B48-genes-12-00299"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Knapp</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>P.</given-names></name></person-group><article-title>Exploration of molecular pathways mediating electric field-directed schwann cell migration by RNA-seq</article-title><source>J. Cell. Physiol.</source><year>2015</year><volume>230</volume><fpage>1515</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1002/jcp.24897</pub-id><pub-id pub-id-type="pmid">25557037</pub-id></element-citation></ref><ref id="B49-genes-12-00299"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Guan</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Bai</surname><given-names>H.</given-names></name></person-group><article-title>Direct Current Electric Field Stimulates Nitric Oxide Production and Promotes NO-Dependent Angiogenesis: Involvement of the PI3K/Akt Signaling Pathway</article-title><source>J. Vasc. Res.</source><year>2020</year><volume>57</volume><fpage>195</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1159/000506517</pub-id><?supplied-pmid 32375152?><pub-id pub-id-type="pmid">32375152</pub-id></element-citation></ref><ref id="B50-genes-12-00299"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Pu</surname><given-names>J.</given-names></name><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Reid</surname><given-names>B.</given-names></name><name><surname>Tai</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Guo</surname><given-names>A.</given-names></name><name><surname>Walczysko</surname><given-names>P.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-&#x003b3; and PTEN</article-title><source>Nat. Cell Biol.</source><year>2006</year><volume>442</volume><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/nature04925</pub-id></element-citation></ref><ref id="B51-genes-12-00299"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Honjo</surname><given-names>K.</given-names></name><name><surname>Ichioka</surname><given-names>H.</given-names></name><name><surname>Oseko</surname><given-names>F.</given-names></name><name><surname>Kishida</surname><given-names>T.</given-names></name><name><surname>Mazda</surname><given-names>O.</given-names></name><name><surname>Kanamura</surname><given-names>N.</given-names></name></person-group><article-title>Electrical stimulation with periodic alternating intervals stimulates neuronal cells to produce neurotrophins and cytokines through activation of mitogen-activated protein kinase pathways</article-title><source>Eur. J. Oral Sci.</source><year>2015</year><volume>123</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1111/eos.12224</pub-id><pub-id pub-id-type="pmid">26510379</pub-id></element-citation></ref><ref id="B52-genes-12-00299"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>K.</given-names></name><name><surname>Kano</surname><given-names>Y.</given-names></name></person-group><article-title>Electrical stimulation induces neurite outgrowth in PC12m3 cells via the p38 mitogen-activated protein kinase pathway</article-title><source>Neurosci. Lett.</source><year>2019</year><volume>698</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2019.01.015</pub-id><pub-id pub-id-type="pmid">30634009</pub-id></element-citation></ref><ref id="B53-genes-12-00299"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name></person-group><article-title>Electrical stimulation facilitates the angiogenesis of human umbilical vein endothelial cells through MAPK/ERK signaling pathway by stimulating FGF2 secretion</article-title><source>Am. J. Physiol. Physiol.</source><year>2019</year><volume>317</volume><fpage>C277</fpage><lpage>C286</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00474.2018</pub-id></element-citation></ref><ref id="B54-genes-12-00299"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>A.W.</given-names></name><name><surname>Schwartz</surname><given-names>G.</given-names></name><name><surname>Meador</surname><given-names>W.</given-names></name><name><surname>Sabatier</surname><given-names>M.J.</given-names></name><name><surname>Mulligan</surname><given-names>A.</given-names></name></person-group><article-title>Electrical stimulation promotes peripheral axon regeneration by enhanced neuronal neurotrophin signaling</article-title><source>Dev. Neurobiol.</source><year>2007</year><volume>67</volume><fpage>158</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/dneu.20339</pub-id><?supplied-pmid 17443780?><pub-id pub-id-type="pmid">17443780</pub-id></element-citation></ref><ref id="B55-genes-12-00299"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>Q.-G.</given-names></name><name><surname>Franz</surname><given-names>C.K.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Dalton</surname><given-names>C.</given-names></name><name><surname>Gordon</surname><given-names>T.</given-names></name><name><surname>Verge</surname><given-names>V.M.K.</given-names></name><name><surname>Midha</surname><given-names>R.</given-names></name><name><surname>Zochodne</surname><given-names>D.W.</given-names></name></person-group><article-title>Accelerated axon outgrowth, guidance, and target reinnervation across nerve transection gaps following a brief electrical stimulation paradigm</article-title><source>J. Neurosurg.</source><year>2012</year><volume>116</volume><fpage>498</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.3171/2011.10.JNS11612</pub-id><pub-id pub-id-type="pmid">22149377</pub-id></element-citation></ref><ref id="B56-genes-12-00299"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>C.</given-names></name><name><surname>Park</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>T.</given-names></name><name><surname>Kang</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>K.-S.</given-names></name><name><surname>Park</surname><given-names>S.-M.</given-names></name></person-group><article-title>Effectiveness of electrical stimulation on nerve regeneration after crush injury: Comparison between invasive and non-invasive stimulation</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0233531</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0233531</pub-id><pub-id pub-id-type="pmid">32453807</pub-id></element-citation></ref><ref id="B57-genes-12-00299"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>K.J.</given-names></name><name><surname>Gordon</surname><given-names>T.</given-names></name><name><surname>Chan</surname><given-names>K.M.</given-names></name><name><surname>Borschel</surname><given-names>G.H.</given-names></name></person-group><article-title>Electrical stimulation to enhance peripheral nerve regeneration: Update in molecular investigations and clinical translation</article-title><source>Exp. Neurol.</source><year>2020</year><volume>332</volume><fpage>113397</fpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113397</pub-id><pub-id pub-id-type="pmid">32628968</pub-id></element-citation></ref><ref id="B58-genes-12-00299"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>T.</given-names></name></person-group><article-title>Electrical stimulation to enhance axon regeneration after peripheral nerve injuries in animal models and humans</article-title><source>Neurotherapeutics</source><year>2016</year><volume>13</volume><fpage>295</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1007/s13311-015-0415-1</pub-id><pub-id pub-id-type="pmid">26754579</pub-id></element-citation></ref><ref id="B59-genes-12-00299"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jara</surname><given-names>J.S.</given-names></name><name><surname>Agger</surname><given-names>S.</given-names></name><name><surname>Hollis</surname><given-names>E.R.I.</given-names></name></person-group><article-title>Functional Electrical Stimulation and the Modulation of the Axon Regeneration Program</article-title><source>Front. Cell Dev. Biol.</source><year>2020</year><volume>8</volume><fpage>736</fpage><pub-id pub-id-type="doi">10.3389/fcell.2020.00736</pub-id><pub-id pub-id-type="pmid">33015031</pub-id></element-citation></ref><ref id="B60-genes-12-00299"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Rochon</surname><given-names>Y.</given-names></name><name><surname>Franza</surname><given-names>B.R.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name></person-group><article-title>Correlation between Protein and mRNA Abundance in Yeast</article-title><source>Mol. Cell. Biol.</source><year>1999</year><volume>19</volume><fpage>1720</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.3.1720</pub-id><pub-id pub-id-type="pmid">10022859</pub-id></element-citation></ref><ref id="B61-genes-12-00299"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenbaum</surname><given-names>D.</given-names></name><name><surname>Colangelo</surname><given-names>C.</given-names></name><name><surname>Williams</surname><given-names>K.</given-names></name><name><surname>Gerstein</surname><given-names>M.</given-names></name></person-group><article-title>Comparing protein abundance and mRNA expression levels on a genomic scale</article-title><source>Genome Biol.</source><year>2003</year><volume>4</volume><fpage>117</fpage><pub-id pub-id-type="doi">10.1186/gb-2003-4-9-117</pub-id><pub-id pub-id-type="pmid">12952525</pub-id></element-citation></ref><ref id="B62-genes-12-00299"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>K.M.</given-names></name><name><surname>Pounds</surname><given-names>J.G.</given-names></name><name><surname>Thrall</surname><given-names>B.D.</given-names></name></person-group><article-title>Data merging for integrated microarray and proteomic analysis</article-title><source>Brief. Funct. Genom. Proteom.</source><year>2006</year><volume>5</volume><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1093/bfgp/ell019</pub-id><?supplied-pmid 16772273?><pub-id pub-id-type="pmid">16772273</pub-id></element-citation></ref><ref id="B63-genes-12-00299"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyler</surname><given-names>S.E.B.</given-names></name></person-group><article-title>Nature&#x02019;s Electric Potential: A Systematic Review of the Role of Bioelectricity in Wound Healing and Regenerative Processes in Animals, Humans, and Plants</article-title><source>Front. Physiol.</source><year>2017</year><volume>8</volume><fpage>02017</fpage><pub-id pub-id-type="doi">10.3389/fphys.2017.00627</pub-id><?supplied-pmid 28928669?><pub-id pub-id-type="pmid">28928669</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="genes-12-00299-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Morphology of hTCEpi cells (<bold>A</bold>) before and (<bold>B</bold>) after AC EF stimulation for 24 h. No significant morphological differences were observed after EF stimulation. Scale bar: 50 &#x000b5;m.</p></caption><graphic xlink:href="genes-12-00299-g001"/></fig><fig id="genes-12-00299-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Hierarchical illustration of differentially expressed genes in hTCEpi cells after treatment with AC EFs for 24 h. Both two-fold upregulated and downregulated genes were clustered. Untreated hTCEpi cells served as control. After 24 h of treatment with AC EFs, RNA was isolated and transcriptome-wide gene level expression profiling was performed using Clariom<sup>TM</sup> S arrays. Affymetrix<sup>&#x000ae;</sup> Transcription Analysis Console<sup>TM</sup> (TAC) software (v.4.0.1.36) was used for array scanning, data analysis, signal estimation, and quality control functionality for the expression arrays, which also allow statistical analysis and provide a list of differentially expressed genes. Expression level analysis was performed using the normalization method based on the processing algorithm called the robust multi-array average (RMA), which was improved by Signal Space Transformation (SST-RMA, Affymetrix). Each array was performed in triplicate. Blue indicates a relatively low expression, whereas red indicates a relatively high expression.</p></caption><graphic xlink:href="genes-12-00299-g002"/></fig><fig id="genes-12-00299-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Validation of the Clariom<sup>TM</sup> S array analyzed transcripts using qRT-PCR. The hTCEpi cells were cultured in the presence of AC EFs and RNA was isolated after 24 h. Reverse transcription was performed using 1 &#x000b5;g of total RNA to prepare cDNA and qRT-PCR was performed to compare the expression analysis of different transcripts using respective primers for Twist1, Notch1, Notch3, Notch4, Jag2, Zeb1, Numb, NFkB, E-Cad, IL8, IL18, IL21, IL27, Ker9 and Ker27. Relative expression patterns were analyzed using the comparative threshold cycle (2<sup>&#x02212;&#x00394;&#x00394;<italic>C</italic>t</sup>) method. Expression values are represented as fold changes over the control on an arbitrary scale after normalization with GAPDH. Further, these transcripts displayed similar expression profile during Clariom<sup>TM</sup> S Arrays. Data represent means &#x000b1; standard deviations of three independent experiments.</p></caption><graphic xlink:href="genes-12-00299-g003"/></fig><fig id="genes-12-00299-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The antibody microarray identified differentially enriched proteins after the treatment of hTCEpi cells with AC EFs. The volcano plot visualizes the <italic>p</italic>-values (adjusted for multiple testing) and corresponding log-fold changes. The log-fold change of the difference in abundance is shown horizontally, whereas the vertical axis represents the significance level. The logFC cutoffs are depicted as vertical lines. The black dots represent analyzed proteins. The horizontal red line indicates an adjusted <italic>p</italic>-value of 0.05, above which all proteins are considered to vary significantly. Proteins with a positive log-fold change display higher abundance in EF-treated samples, whereas proteins with a negative value display higher abundance in control samples.</p></caption><graphic xlink:href="genes-12-00299-g004"/></fig><fig id="genes-12-00299-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Heatmap of differentially expressed proteins in hTCEpi cells after treatment with AC EFs for 24 h. Both upregulated and downregulated proteins with logFC values of 0.3 were clustered. Untreated hTCEpi cells served as control.</p></caption><graphic xlink:href="genes-12-00299-g005"/></fig><fig id="genes-12-00299-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Enriched biological processes after treatment of hTCEpi cells with AC EFs for 24 h. Significantly enriched biological processes following analysis of the gene array data are highlighted as an interactive hierarchical clustering tree using ShinyGO. Biological processes with many shared genes are clustered together. Bigger dots indicate more significant <italic>p</italic>-values. Enriched biological processes that were similar after analysis of both gene and proteins array data are marked and highlighted. Analysis was performed using ShinyGO (v.0.61) (Available online: <uri xlink:href="http://bioinformatics.sdstate.edu/go/">http://bioinformatics.sdstate.edu/go/</uri> (accessed on 6 January 2021)).</p></caption><graphic xlink:href="genes-12-00299-g006"/></fig><fig id="genes-12-00299-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Enriched biological processes after treatment of hTCEpi cells with AC EFs for 24 h. Significantly enriched biological processes following analysis of the antibody array data are highlighted as an interactive hierarchical clustering tree using ShinyGO. Biological processes with many shared genes are clustered together. Bigger dots indicate more significant <italic>p</italic>-values. Enriched biological processes that were similar after analysis of both gene and protein array data are marked and highlighted. Analysis was performed using ShinyGO (v.0.61) (Available online: <uri xlink:href="http://bioinformatics.sdstate.edu/go/">http://bioinformatics.sdstate.edu/go/</uri> (accessed 6 January 2021)).</p></caption><graphic xlink:href="genes-12-00299-g007"/></fig><fig id="genes-12-00299-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Enriched molecular pathways after treatment of hTCEpi cells with AC EFs for 24 h. The relationships between pathways are depicted and highlighted as an interactive graphical network using ShinyGO. Pathways enriched following analysis of the gene array data are shown. Two pathways (nodes) are connected after sharing 20% or more genes. Enriched pathways that were similar after analysis of both gene and protein array data are marked and highlighted. Node colors illustrate enrichment, whereby darker nodes represent significantly enriched gene sets, while bigger nodes represent larger gene sets. Thicker edges represent more overlapped genes. Analysis was performed using ShinyGO (v.0.61) (Available online: <uri xlink:href="http://bioinformatics.sdstate.edu/go/">http://bioinformatics.sdstate.edu/go/</uri> (accessed on 6 January 2021)). Edge cut-off = 0.2 and FDR <italic>p</italic>-value cut-off = 0.05.</p></caption><graphic xlink:href="genes-12-00299-g008"/></fig><fig id="genes-12-00299-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Enriched molecular pathways after treatment of hTCEpi cells with AC EFs for 24 h. The relationships between pathways are depicted and highlighted as an interactive graphical network using ShinyGO. Pathways enriched following analysis of the antibody array data are shown. Two pathways (nodes) are connected after sharing 20% or more genes. Enriched pathways that were similar after analysis of both gene and protein array data are marked and highlighted. Node colors illustrate enrichment, whereby darker nodes represent significantly enriched gene sets, while bigger nodes represent larger gene sets. Thicker edges represent more overlapped genes. Analysis was performed using ShinyGO (v.0.61) (Available online: <uri xlink:href="http://bioinformatics.sdstate.edu/go/">http://bioinformatics.sdstate.edu/go/</uri> (accessed on 6 January 2021)). Edge cut-off = 0.2 and FDR <italic>p</italic>-value cut-off = 0.05.</p></caption><graphic xlink:href="genes-12-00299-g009"/></fig><table-wrap id="genes-12-00299-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-12-00299-t001_Table 1</object-id><label>Table 1</label><caption><p>List of primers used in the present study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer Sequence (5&#x02032;-3&#x02032;)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GenBank <break/>Accession</th></tr></thead><tbody><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Twist1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CAGCCTGAGCAACAGCGAGGA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_000474</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CGAACGCCTCGTTCAGCGAC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Notch1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCAGTGCTTCCAGAGTGCCACC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_017617</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AACCGGAACTTCTTGGTCTCCAGG</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Notch3</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GGCCAGGCCATGGTCTTCC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_000435 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TCAGGGAACCAGAGGGTGCTG</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Notch4</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">AGGCTGGAGCCAACCCCAAC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_004557</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAGCCCCTTCCAGCAGCGT</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Jag2</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CCTGATTGGCGGCTATTACTGTGA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_002226</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCCGCAGCCATCGATCACTC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Zeb1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCAGGGCACACCAGAAGCCA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_001128128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GTGAGCTATAGGAGCCAGAATGGGAA</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Numb</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CAAGCTAATGGCACTGACTCAGCC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_001005743</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTGAGGGTGGCCTGCAGTGC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NFkB</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCACCTAGCTGCCAAAGAAGGAC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_001165412</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GCTCCTGCTGCTTTGAGAAGAGC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">E-cadherin</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCTTGGATTTTGAGGCCAAGCA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_004360</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AATCTCCAGCCAGTTGGCAGTGTC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IL8</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CGTGGCTCTCTTGGCAGCC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_000584</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGTGTTGGCGCAGTGTGGTC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IL18</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CCAAGGAAATCGGCCTCTATTTG</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_001562</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TCAGGAGGATTCATTTCCTTAAAGGA</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IL21</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCCACATGATTAGAATGCGTCAAC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_021803</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGTATTTGCTGACTTTAGTTGGGCC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">IL27</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CGGAGCGTCTCTGCTTCATCTC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_145659</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGGTTGAATCCTGCAGCCAGC</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ker9</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">CTCTCCTGGACATTGACAACACTCGC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_000226</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGCACCTGCCGCAGGCCAT</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ker27</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GCGAGCTGAGTACGAAGCCCTCG</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_181537</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CTCATTCCGGGCTGAGGTGGTG</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">GAPDH</td><td align="center" valign="middle" rowspan="1" colspan="1">Fwd</td><td align="center" valign="middle" rowspan="1" colspan="1">GGATATTGTTGCCATCAATGACCC</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">NM_002046</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TCTCGCTCCTGGAAGATGGTGA</td></tr></tbody></table></table-wrap><table-wrap id="genes-12-00299-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-12-00299-t002_Table 2</object-id><label>Table 2</label><caption><p>Significantly impacted pathways in hTCEpi cells after AC EF stimulation based on the Clariom&#x02122; S gene array data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">KEGG <break/>Pathway</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pathway <break/>Description</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Observed <break/>Gene Count</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">False Discovery Rate</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa00520</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amino sugar and nucleotide sugar metabolism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 of 48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 of 293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04978</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mineral absorption</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 of 51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05162</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 of 133</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05164</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Influenza A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 of 168</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05202</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transcriptional misregulation in cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 of 169</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05418</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluid shear stress and atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 of 133</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0036</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa01100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metabolic pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 of 1250</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa01212</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatty acid metabolism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 of 48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05160</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatitis C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 of 131</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathways in cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49 of 515</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05203</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral carcinogenesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 of 183</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05206</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MicroRNAs in cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 of 149</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05219</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bladder cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 of 41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0074</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04110</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell cycle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 of 123</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0076</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05168</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herpes simplex infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 of 181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0076</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04360</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Axon guidance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 of 173</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0093</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04657</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-17 signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 of 92</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0194</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04060</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytokine-cytokine receptor interaction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28 of 263</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0206</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04914</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Progesterone-mediated oocyte maturation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 of 94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.021</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa00970</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aminoacyl-tRNA biosynthesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 of 44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0213</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05161</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatitis B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 of 142</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0229</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa01040</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biosynthesis of unsaturated fatty acids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 of 23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0426</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05322</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systemic lupus erythematosus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 of 94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0454</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04217</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Necroptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 of 155</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0474</td></tr></tbody></table><table-wrap-foot><fn><p>Analysis of the gene array data was performed using TAC software (v.4.0.1.36) and putative differentially expressed up- and downregulated gene function was analyzed to identify impacted signaling pathways using the STRING database, version 11 (Available online: <uri xlink:href="http://string-db.org">http://string-db.org</uri> (accessed on 14 December 2020)). KEGG = Kyoto Encyclopedia of Genes and Genomes.</p></fn></table-wrap-foot></table-wrap><table-wrap id="genes-12-00299-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-12-00299-t003_Table 3</object-id><label>Table 3</label><caption><p>Significantly impacted signaling pathways in hTCEpi cells after AC EF stimulation based on the antibody microarray data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">KEGG Pathway</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pathway Description</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protein Count</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">False Discovery Rate</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Matching Proteins <break/>in Network</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04668</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.95 &#x000d7; 10<sup>&#x02212;13</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, ICAM1, VCAM1, IL15, CSF2, FOS, CASP3, CFLAR, SELE, FAS, MAPK9, TNF, MAP2K4, PGAM5, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pathways in cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.95 &#x000d7; 10<sup>&#x02212;11</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, HGF, IFNG, CCND2, AKT3, IL7, FGF2, STAT3, TP53, ERBB2, IL15, HSP90B1, IL7R, FOS, CASP3, GSTM1, KLK3, MET, MMP1, CASP9, FAS, RAC1, IL2RA, ETS1, JAK3, MAPK9, CUL2 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05418</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluid shear stress and atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.95 &#x000d7; 10<sup>&#x02212;11</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, IFNG, AKT3, KDR, ICAM1, TP53, VCAM1, HSP90B1, FOS, GSTM1, SELE, CAV3, RAC1, MAPK9, TNF, MAP2K4 </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.06 &#x000d7; 10<sup>&#x02212;11</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, HGF, HSPB1, AKT3, KDR, FGF2, TP53, ERBB2, CD14, FOS, CASP3, MET, FAS, RAC1, HSPA1A, MAPK9, TNF, MAP2K4, DDIT3, NTF4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04060</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytokine-cytokine receptor interaction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.06 &#x000d7; 10<sup>&#x02212;11</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HGF, IFNG, TNFSF10, CCR7, IL7, KDR, CXCL13, IL15, CSF2, CCL11, IL7R, MET, FAS, IL2RA, CCL8, TNF, IL10, TNFSF14, CCL5, TNFRSF9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04657</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-17 signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.29 &#x000d7; 10<sup>&#x02212;10</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, IFNG, CSF2, HSP90B1, CCL11, FOS, CASP3, MMP1, MAPK4, MAPK9, TNF, MUC5B</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04151</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI3K-Akt signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.07 &#x000d7; 10<sup>&#x02212;10</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, HGF, VTN, CCND2, AKT3, IL7, KDR, FGF2, TP53, ERBB2, ITGA5, HSP90B1, IL7R, MET, CASP9, RAC1, THBS3, IL2RA, JAK3, PPP2R5D, NTF4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04933<break/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AGE-RAGE signaling pathway in diabetic complications</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.79 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, STAT3, ICAM1, VCAM1, CASP3, SELE, RAC1, MAPK9, TNF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04660</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T cell receptor signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.95 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, IFNG, AKT3, CSF2, FOS, CD28, MAPK9, TNF, PTPRC, IL10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04620</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toll-like receptor signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.21 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, CD14, FOS, CD86, RAC1, MAPK9, TNF, MAP2K4, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04510</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Focal adhesion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.84 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, HGF, VTN, CCND2, AKT3, KDR, ERBB2, ITGA5, MET, CAV3, RAC1, THBS3, ACTN1, MAPK9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05164</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Influenza A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.98 &#x000d7; 10<sup>&#x02212;8</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, IFNG, TNFSF10, AKT3, ICAM1, CASP9, FAS, HSPA1A, MAPK9, TNF, MAP2K4, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04630</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jak-STAT signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.49 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFNG, CCND2, AKT3, IL7, STAT3, IL15, CSF2, IL7R, AOX1, IL2RA, JAK3, IL10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04068</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FoxO signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.99 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, TNFSF10, CCND2, AKT3, STAT3, ATM, IL7R, BNIP3, MAPK9, IL10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05162</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Measles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.63 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFNG, TNFSF10, CCND2, AKT3, STAT3, TP53, CD28, FAS, HSPA1A, IL2RA, JAK3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05161</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatitis B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.35 &#x000d7; 10<sup>&#x02212;7</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, AKT3, STAT3, TP53, FOS, CASP3, CASP9, FAS, MAPK9, <break/>TNF, MAP2K4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04664</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fc epsilon RI signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.19 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, CSF2, RAC1, MAPK9, TNF, MAP2K4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05168</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herpes simplex infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.12 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CDC34, IFNG, TP53, IL15, FOS, CASP3, FAS, MAPK9, TNF, TNFSF1, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04514</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell adhesion molecules (CAMs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.92 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SELP, ICAM1, VCAM1, CD28, SELE, CD86, VTCN1, CD99, PDCD1LG2, PTPRC</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04370</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VEGF signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.52 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, HSPB1, AKT3, KDR, CASP9, RAC1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04217</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Necroptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFNG, TNFSF10, STAT3, CFLAR, FAS, FAF1, JAK3, MAPK9, TNF, PGAM5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p53 signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.92 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCND2, TP53, ATM, CASP3, CASP9, FAS, CHEK2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04917</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prolactin signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.02 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, CCND2, AKT3, STAT3, FOS, MAPK9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04062</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chemokine signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.16 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, CCR7, AKT3, STAT3, CXCL13, CCL11, RAC1, CCL8, JAK3, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04512</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ECM-receptor interaction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.07 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VTN, ITGA5, GP1BA, CD47, THBS3, HMMR, CD44</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04071</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sphingolipid signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.57 &#x000d7; 10<sup>&#x02212;5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, TP53, RAC1, MAPK9, TNF, PPP2R5D</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04064</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF-kappa B signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICAM1, ATM, VCAM1, CD14, CFLAR, TNF, TNFSF14</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04066</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIF-1 signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, IFNG, ENO1, AKT3, STAT3, ERBB2, CUL2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ras signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, HGF, AKT3, KDR, FGF2, MET, RAC1, ETS1, MAPK9, NTF4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04722</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotrophin signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00034</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, TP53, RAC1, MAPK9, NTF4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04926</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Relaxin signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.00066</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, FOS, MMP1, MAPK9, MAP2K4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rap1 signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, HGF, AKT3, KDR, FGF2, MET, RAC1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa05219</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bladder cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, TP53, ERBB2, MMP1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04110</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell cycle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0025</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCND2, TP53, ATM, CDC25C, CHEK2, CDKN1C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ErbB signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0027</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, AKT3, ERBB2, MAPK9, MAP2K4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04550</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Signaling pathways regulating pluripotency of stem cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0042</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, AKT3, FGF2, STAT3, JAK3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04920</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adipocytokine signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0089</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AKT3, STAT3, MAPK9, TNF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04919</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thyroid hormone signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0094</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, AKT3, NCOR1, TP53, CASP9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04662</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B cell receptor signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0096</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, AKT3, FOS, RAC1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04915</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Estrogen signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0154</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, AKT3, HSP90B1, FOS, HSPA1A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04024</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cAMP signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0179</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, SOX9, AKT3, FOS, RAC1, MAPK9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04912</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GnRH signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0179</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, MAPK9, MAP2K4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04310</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wnt signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0197</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMP7, CCND2, TP53, RAC1, MAPK9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04810</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation of actin cytoskeleton</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0213</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK1, FGF2, ITGA5, CD14, RAC1, ACTN1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04141</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein processing in endoplasmic reticulum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0298</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMFR, HSP90B1, HSPA1A, MAPK9, DDIT3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04621</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NOD-like receptor signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0329</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK1, MAPK9, TNF, CCL5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa04622</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RIG-I-like receptor signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0468</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MAPK12, MAPK9, TNF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hsa03320</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PPAR signaling pathway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0497</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FABP2, FABP5, MMP1</td></tr></tbody></table><table-wrap-foot><fn><p>After antibody microarray, the functions of highly enriched proteins and their interactions with other proteins were analyzed to identify impacted signaling pathways using the STRING database, version 11 (Available online: <uri xlink:href="http://string-db.org">http://string-db.org</uri> (accessed on 14 December 2020)). KEGG = Kyoto Encyclopedia of Genes and Genomes.</p></fn></table-wrap-foot></table-wrap></floats-group></article>